Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 15, 2020
The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRITiebao Meng, Ni He, Haoqiang He, et al.
The Journal of Comparative Neurology|April 22, 2008
Structural remodeling of nucleus ambiguus projections to cardiac ganglia following chronic intermittent hypoxia in C57BL/6J miceMin Lin, Jing Ai, Lihua Li, et al.
BMC Cancer|May 8, 2015
URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathwaySizhong Xing, Bing Zhang, Ruixi Hua, et al.
Cancer Letters|September 26, 2025
An anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) and chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer: A phase Ib studyMing Bai, Ning Li, Xianli Yin, et al.
The Journal of Comparative Neurology|May 28, 2010
Structural remodeling of vagal afferent innervation of aortic arch and nucleus ambiguus (NA) projections to cardiac ganglia in a transgenic mouse model of type 1 diabetes (OVE26)Lihua Li, Chenghui Huang, Jing Ai, et al.
Frontiers in Oncology|January 7, 2022
Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver MetastasisHonghua Peng, Guifeng Liu, Ying Bao, et al.
Rheumatology (Oxford, England)|July 3, 2023
Efficacy and safety of telitacicept in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled, phase 2 trialDong Xu, Jianmin Fang, Shangzhu Zhang, et al.
The New England Journal of Medicine|October 15, 2025
A Phase 3 Trial of Telitacicept for Systemic Lupus ErythematosusRonald F van Vollenhoven, Li Wang, Joan T Merrill, et al.
Ebiomedicine|February 6, 2026
Environmental ciprofloxacin triggers pregnancy loss: senescence-driven miscarriage via TRIM21-mediated MFF degradationYi Sun 孙义, Yanbing Lin 林晏冰, Shuaishuai Xing 幸帅帅, et al.
Annals of the Rheumatic Diseases|December 21, 2023
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trialDi Wu, Jing Li, Dong Xu, et al.
Pageof 6